0
0
0
To amend the Public Health Service Act to codify that the default expectation for licensure of biological products as biosimilar does not include clinical studies assessing pharmacodynamics or comparative clinical efficacy, and for other purposes.
7/15/2026, 8:07 AM
Summary of Bill HR 9661
H.R. 9661 in the 119th Congress, introduced on July 14, 2026, aims to amend the Public Health Service Act regarding the licensure of biological products as biosimilar. The bill seeks to establish that the default expectation for licensure does not involve clinical studies assessing pharmacodynamics or comparative clinical efficacy.
Current Status of Bill HR 9661
Bill HR 9661 is currently in the status of Bill Introduced since July 14, 2026. Bill HR 9661 was introduced during Congress 119 and was introduced to the House on July 14, 2026. Bill HR 9661's most recent activity was Referred to the House Committee on Energy and Commerce. as of July 14, 2026
Bipartisan Support of Bill HR 9661
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
1Democrat Cosponsors
1Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 9661
Primary Policy Focus
Alternate Title(s) of Bill HR 9661
To amend the Public Health Service Act to codify that the default expectation for licensure of biological products as biosimilar does not include clinical studies assessing pharmacodynamics or comparative clinical efficacy, and for other purposes.
To amend the Public Health Service Act to codify that the default expectation for licensure of biological products as biosimilar does not include clinical studies assessing pharmacodynamics or comparative clinical efficacy, and for other purposes.
Comments
Sponsors and Cosponsors of HR 9661
Latest Bills
NIH IMPROVE Act
Bill HR 6238July 15, 2026
Providing for consideration of the bill (H.R. 139) to make daylight savings time permanent, and for other purposes; providing for consideration of the bill (H.R. 8595) making appropriations for national security, Department of State, and related programs for the fiscal year ending September 30, 2027, and for other purposes; providing for consideration of the bill (H.R. 9237) to amend titles 10 and 38, United States Code, and other Federal laws, to improve benefits for veterans and the administration of the Department of Veterans Affairs; providing for consideration of the bill (H.R. 1181) to prohibit payment card networks and covered entities from requiring the use of or assigning merchant category codes that distinguish a firearms retailer from general-merchandise retailer or sporting-goods retailer, and for other purposes; and for other purposes.
Bill HRES 1423July 15, 2026
Stop the Sexualization of Children Act
Bill S 4925July 15, 2026
Preserving Patient Access Act
Bill S 4924July 15, 2026
Protecting Communities from Data Center Impacts Act of 2026
Bill HR 9629July 15, 2026
Rural Hospital Emergency Room Guarantee Act
Bill S 4927July 15, 2026
Gas Money Saved Act
Bill S 4908July 15, 2026
Reproductive Health Travel Fund Act of 2026
Bill S 4922July 15, 2026
Northwest Endangered Salmon Predation Prevention Act of 2026
Bill HR 9621July 15, 2026
Medicaid RAC Improvement Act of 2026
Bill S 4898July 15, 2026